Seres Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript
Good morning, and thank you for joining us today. My name is [Malika], and I am an associate in JPMorgan's health care group.
Before I introduce you to our presenters today, I want to call your attention to the blue button on your screen. This is where you will submit questions that will be addressed during Q&A.
With that, I am pleased to introduce you to Eric Shaff, CEO; Carlo Tanzi, Investor Relations; David Ege, Chief Technology Officer; Matt Henn, Chief Scientific Officer; Lisa von Moltke, Chief Marketing Officer; Terri Young, Chief Commercial and Strategy Officer; and David Arkowitz, Chief Financial Officer at Seres Therapeutics. I know that they are all very excited to tell you about their story, so we'll turn it over to Eric and his team.
Well, good morning, everybody. And let me start by saying, I hope everyone on the line is healthy and well, and we look forward to speaking together in person, hopefully soon.
Thank you to [Malika] and
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |